CD274 and metastatic neoplasm: In the last few years, a wide use of immunotherapy based on PD1/PDL1 and other ICIs has gradually provided new clinical treatment modalities, especially for patients with locally advanced or metastatic tumors who have lost the chance for taking surgery (26, 27).